Festschrift Issue Honoring Judah Folkman, M.D. in Lymphatic Research and Biology
January 6, 2009
NEW ROCHELLE, N.Y., Jan. 6 /PRNewswire/ – Dedicated to the memory and scientific accomplishments of Dr.
Judah Folkman, who pioneered the fields of angiogenesis and vasculogenesis and shed light on the link between blood supply and neoplastic disease, the newly released special double issue (Volume 6, Number 3-4) of Lymphatic Research and Biology includes a series of papers that reflect the research impact of one of the pre-eminent physician-scientists of his generation. Lymphatic Research and Biology is a peer-reviewed journal published by
Mary Ann Liebert, Inc. (www.liebertpub.com). The issue is available free online at www.liebertpub.com/lrb
“Not only did
Judah Folkman single-handedly create the research discipline of angiogenesis, he also played a very fundamental role in the extension of the same principles to the field of lymphangiogenesis research,” says
Stanley G. Rockson, MD, Editor-in-Chief of the Journal and Chair of the Scientific Advisory Board of the Lymphatic Research Foundation. Dr. Rockson, who is the Chief of Consultative Cardiology, the Allan and Tina Neill Professor of Lymphatic Research and Medicine, and Director of the Stanford Center for Lymphatic and Venous Disorders, Stanford University School of Medicine, feels that “his impact as a teacher and mentor is almost incalculable, and we are proud to present these contributions by leading scientists whose training and career path directly reflect the impact of Dr. Folkman’s work and teaching.”
Leah Cueni and
Michael Detmar provide an in-depth review of the field in “The Lymphatic System in Health and Disease,” and
Carrie Shawber and
Jan Kitajewski describe “Arterial Regulators Taken Up by Lymphatics.” In the paper “Why and How Do Tumors Stimulate Lymphangiogenesis?,”
Yihai Cao explains the processes behind increased lymphatic supply to cancerous lesions.
Dean Felsher explores the phenomena of oncogene addiction, cellular senescence, and the angiogenic switch in a report entitled, “Reversing Cancer From Inside and Out.” In a forward-looking review,
Steven Stacker and
Marc Achen present “From Anti-Angiogenesis to Anti-Lymphangiogenesis: Emerging Trends in Cancer Therapy.” A report by
Michael Mancuso,
Frank Kuhnert, and
Calvin Kuo focuses on “Developmental Angiogenesis of the Central Nervous System.”
Lymphatic Research and Biology is an authoritative peer-reviewed journal published quarterly in print and online. As the official journal of the Lymphatic Research Foundation, it provides an interdisciplinary forum for the world’s leading biomedical investigators to discuss current and anticipated developments in lymphatic biology and pathology. Original research derives from a variety of investigative disciplines, including genetics, biochemistry and biophysics, cellular and molecular biology, physiology and pharmacology, anatomy, developmental biology, and pathology. A complete table of contents and free sample issue may be viewed online at www.liebertpub.com/lrb
Mary Ann Liebert, Inc., is a privately held, fully integrated media company known for establishing authoritative peer-reviewed journals in many promising areas of science and biomedical research, including DNA and Cell Biology. Its biotechnology trade magazine, Genetic Engineering & Biotechnology News (GEN), was the first in its field and is today the industry’s most widely read publication worldwide. A complete list of the firm’s 60 journals, books, and newsmagazines is available at www.liebertpub.com
Mary Ann Liebert, Inc.
140 Huguenot St., New Rochelle, NY 10801-5215
Phone: (914) 740-2100
(800) M-LIEBERT
Fax: (914) 740-2101
www.liebertpub.com
Contact:
Vicki Cohn,
Mary Ann Liebert, Inc., (914) 740-2100, ext. 2156, vcohn@liebertpub.com
SOURCE
Mary Ann Liebert, Inc.
Source: newswire
Topics:
Health Medical Pharma,
biotechnology,
Academic publishing,
Scientific journals,
Lymphatic system,
Angiogenesis,
Judah Folkman,
Liebert,
Lymphangiogenesis,
Publishers,
New Rochelle, New York,
Mary Ann Liebert, Inc.,
Mary Ann Liebert Inc.